ISSN: 1359-6101

Journal Home

Journal Guideline

Cytokine and Growth Factor Reviews Q1 Unclaimed

Elsevier BV United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cytokine and Growth Factor Reviews is a journal indexed in SJR in Biochemistry, Genetics and Molecular Biology (miscellaneous) and Immunology with an H index of 158. It has an SJR impact factor of 2,214 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,214.

Cytokine and Growth Factor Reviews focuses its scope in these topics and keywords: t, cytokines, factor, achieve, valuable, regulatory, antiretroviral, modulates, strategy, therapy, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1) Endocrinology, Diabetes and Metabolism (Q1) Immunology (Q1) Immunology and Allergy (Q1) Immunology and Allergy (Q1)

Price

- €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

2,214

SJR Impact factor

158

H Index

70

Total Docs (Last Year)

154

Total Docs (3 years)

7476

Total Refs

1139

Total Cites (3 years)

152

Citable Docs (3 years)

7

Cites/Doc (2 years)

106,8

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Molecular Systems Biology Q1
EMBO Journal Q1
Nature Protocols Q1
Annals of the Rheumatic Diseases Q1
Cell Reports Q1

Compare this journals

Aims and Scope

Best articles by citations

Chemokines and tuberculosis

Regulation of retinoic acid signaling in the embryonic nervous system: a master differentiation factor

Chemokines provide the sustained inflammatory bridge between innate and acquired immunity

Interleukin-21 (IL-21)-mediated pathways in T cell-mediated disease

Interleukin-21: A new modulator of immunity, infection, and cancer

Cytokines revisited at Hilton Head

Let me in: Control of HIV nuclear entry at the nuclear envelope

Erratum to "Human immunodeficiency virus type-1 and chemokines: beyond competition for common cellular receptors" [Cytokine & Growth Factor Reviews 12(2/3) 219-243]

Can cord blood cells support the cytokine storm in GvHD?

TGF-beta in the central nervous system: Potential roles in ischemic injury and neurodegenerative diseases

Novel neurotrophin-1/B cell-stimulating factor-3 (NNT-1/BSF-3) / cardiotrophin-like cytokine (CLC) - a novel gp130 cytokine with pleiotropic functions

Interleukin-4 receptor signaling and its binding mechanism: A therapeutic insight from inhibitors tool box

SHOW MORE ARTICLES

TGF-beta: the missing link in CD4+CD25+ regulatory T cell-mediated immunosuppression

Pivotal role for TGF-beta in infectious heart disease: The case of Trypanosoma cruzi infection and consequent Chagasic myocardiopathy

Novel non-angiogenic role for mesenchymal stem cell-derived vascular endothelial growth factor on keratinocytes during wound healing

Introduction to Innate Sensing and Response to Pathogens (Part 2)

Oncolytic parvoviruses as cancer therapeutics

REMOVED: The caveolin triad: caveolae biogenesis, cholesterol trafficking, and signal transduction

HIV chemokine receptor inhibitors as novel anti-HIV drugs

The angiopoietin/TIE receptor system: Focusing its role for ischemia-reperfusion injury

Evaluating the potential of IL-27 as a novel therapeutic agent in HIV-1 infection

Insight into interleukin-37: The potential therapeutic target in allergic diseases

Bone morphogenetic proteins in craniofacial and periodontal tissue engineering: Experimental studies in the non-human primate Papio ursinus

CD100/Sema4D, a lymphocyte semaphorin involved in the regulation of humoral and cellular immune responses